Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bupropion mimics a transient ischemic attack.

L M Humma1, M P Swims

  • 1University of Florida, Gainesville, USA.

The Annals of Pharmacotherapy
|April 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of human beta(2)-adrenoceptor haplotypes by denaturation selective amplification and subtractive genotyping.

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice·2002
Same author

Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia.

The American journal of cardiology·2001
Same author

Sequencing of beta 2-adrenoceptor gene PCR products using Taq BigDye terminator chemistry results in inaccurate base calling.

BioTechniques·2000
Same author

Technology assessment and the drug use process.

The American journal of managed care·1999
Same author

Sudden cryptococcal deafness.

Tennessee medicine : journal of the Tennessee Medical Association·1998
Same author

Dropped head syndrome.

Neurology·1997
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Bupropion, used for smoking cessation, may cause transient ischemic attack-like symptoms. A patient experienced these neurological issues, which resolved upon bupropion discontinuation and recurred upon re-challenge.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Bupropion is a widely prescribed medication for smoking cessation.
  • Transient ischemic attacks (TIAs) are temporary disruptions of blood flow to the brain.
  • Understanding medication side effects is crucial for patient safety.

Observation:

  • A 67-year-old male developed paresthesia, dizziness, tinnitus, confusion, and gait impairment.
  • These symptoms emerged shortly after initiating bupropion for smoking cessation.
  • Neurological symptoms resolved upon bupropion discontinuation and reappeared after re-challenge.

Findings:

  • The patient's symptoms mimicked transient ischemic attacks.
  • Vertebral basilar artery disease was ruled out through diagnostic testing.

Related Experiment Videos

  • This specific combination of bupropion-induced neurological symptoms has not been previously reported.

    • Implications:

    • Bupropion may induce neurological symptoms that resemble TIAs.
    • Clinicians should consider bupropion as a potential cause of TIA-like symptoms in patients.
    • Further investigation into bupropion's neurological side effect profile is warranted.